| Stage | SPXC | % of rev | LECO | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $715M | 100.00% | $1.2B | 100.00% | LECO ×1.71 |
| Gross profit | $280M | 39.12% | $425M | 34.80% | SPXC +4.3pp |
| Operating income | $115M | 16.14% | $211M | 17.31% | LECO +1.2pp |
| Pre-tax income | $106M | 14.88% | $200M | 16.38% | LECO +1.5pp |
| Net income | $82M | 11.46% | $144M | 11.82% | LECO +0.4pp |
| Stage | SPXC | LECO | Gap · A − B |
|---|---|---|---|
| Revenue | $715M100.00% | $1.2B100.00% | LECO ×1.71 |
| Gross profit | 39.12%$280M | 34.80%$425M | SPXC +4.3pp |
| Operating income | 16.14%$115M | 17.31%$211M | LECO +1.2pp |
| Pre-tax income | 14.88%$106M | 16.38%$200M | LECO +1.5pp |
| Net income |
| 11.46%$82M |
| 11.82%$144M |
| LECO +0.4pp |
No shared counterparties.